US Broker Ratings

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling an 84.89% Potential Upside with Strong Buy Ratings

Stevanato Group S.p.A. (NYSE: STVN), a stalwart in the healthcare sector, has been drawing significant attention from the investment community. Known for its robust portfolio in medical instruments and supplies,..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Leader with 60% Upside Potential

Doximity, Inc. (NYSE: DOCS) is a prominent player in the health information services industry, offering a robust digital platform tailored for medical professionals. Headquartered in San Francisco, this healthcare technology..

Corcept Therapeutics (CORT) Stock Analysis: A Promising Biotech Play with 130% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has captured investor attention with its robust pipeline and significant upside potential. Specializing in the development of treatments..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with Strategic Growth Potential

Baxter International Inc. (NYSE: BAX), a key player in the healthcare sector, stands as a versatile provider of medical instruments and supplies, with a robust portfolio of products spanning intravenous..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in Oncology with a 4.78% Upside

Exelixis, Inc. (NASDAQ: EXEL) stands as a prominent player in the biotechnology sector, focusing on developing groundbreaking treatments for challenging cancer types. Headquartered in Alameda, California, Exelixis has made significant..

CVS Health Corporation (CVS) Stock Analysis: A 20.94% Upside Potential Amidst Strong Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a prominent player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $99.46 billion, CVS is a..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing the 14.08% Potential Upside Amidst Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, has captured investor attention with its significant market cap of $18.48 billion and a compelling potential upside of..

Ascendis Pharma (ASND) Stock Analysis: A Biotech Powerhouse with a 24.93% Upside Potential

Ascendis Pharma A/S, trading under the ticker ASND, is capturing the attention of investors with its significant growth potential in the biotechnology sector. Based in Hellerup, Denmark, Ascendis Pharma specializes..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Revenue Growth and Strategic Partnerships Drive Biotechnology Leader

For investors with a keen eye on the healthcare and biotechnology sectors, Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling case, driven by its innovative technology, robust partnerships, and impressive..

Novo Nordisk A/S (NVO) Stock Analysis: Uncovering a 15.42% Potential Upside in the Healthcare Giant

Novo Nordisk A/S (NYSE: NVO), a leading player in the healthcare sector, primarily focuses on diabetes and obesity care, as well as rare diseases. With a staggering market capitalization of..

ICON plc (ICLR) Stock Analysis: Unlocking a 37% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a pivotal player in the healthcare sector, has caught the attention of investors with its robust potential upside of 37.04%. As a leading clinical research organization,..

Align Technology, Inc. (ALGN) Stock Analysis: Navigating a 5.9% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector specializing in medical instruments and supplies, is making waves with its innovative solutions in the orthodontic industry. Known..

AstraZeneca PLC (AZN)

⚠️ No article content returned.

..

Viatris Inc. (VTRS) Stock Analysis: Navigating a Complex Healthcare Landscape with Potential Value Play

As investors continue to navigate the ever-evolving healthcare sector, Viatris Inc. (NASDAQ: VTRS) emerges as an intriguing player in the market. With a market capitalization of $16.83 billion, Viatris is..

Charles River Laboratories (CRL) Stock Analysis: Exploring Its 14% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a prominent player in the healthcare sector, specializing in diagnostics and research. Headquartered in Wilmington, Massachusetts, the company plays a crucial..

ResMed Inc. (RMD) Stock Analysis: Exploring a 9.51% Potential Upside in the Healthcare Sector

Investors keen on the healthcare sector have likely noticed ResMed Inc. (NYSE: RMD), a leading player in medical instruments and supplies. With a market capitalization of $39.65 billion, ResMed stands..

DexCom, Inc. (DXCM) Investor Outlook: Analyzing a 21.76% Potential Upside in the Medical Device Market

DexCom, Inc. (DXCM), a leading player in the healthcare sector specializing in medical devices, is making waves among investors for its innovative continuous glucose monitoring (CGM) systems. As a company..

DaVita Inc. (DVA) Investor Outlook: Analyzing the Healthcare Leader with a 7.73% Upside Potential

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. With a market capitalization of $9.41 billion, DaVita has..

Haleon plc (HLN) Stock Analysis: Exploring the 7.67% Potential Upside for Investors

Haleon plc (HLN) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With a market capitalization of $48.9..

Incyte Corporation (INCY) Stock Analysis: Evaluating Growth Prospects Amid a Promising Pipeline in the Biotechnology Sector

Incyte Corporation (NASDAQ: INCY) is a renowned player in the biotechnology sector, offering innovative solutions through its diverse portfolio of therapeutics. With a market capitalization of $21.28 billion, the company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds